Mallory G B
Allergy and Pulmonary Medicine Division, St. Louis Children's Hospital, MO 63110, USA.
Semin Thorac Cardiovasc Surg. 1996 Jul;8(3):305-12.
The major challenges to success in the modern era of lung transplantation are the problems of graft infection and rejection. The lung is the only solid organ in which infection is virtually guaranteed after transplantation. Clinical management of lung transplantation candidates includes testing for previous and current infections and appropriate immunizations. An aggressive prophylactic regimen against infection after lung transplantation is tailored to the individual patient's underlying disease and infection history. A high index of suspicion and frequent testing, including rapid viral diagnosis and flexible fiberoptic bronchoscopy with bronchoalveolar lavage, have become the standard in posttransplantation medical management. The problems of acute and chronic graft rejection seem to be more frequent and severe in lung transplant recipients than in those who receive other solid organ transplants. Anticipation and aggressive treatment of early acute graft rejection are critical aspects of the care of patients in the first months after transplantation. Bronchiolitis obliterans, which is caused by chronic graft rejection, is the biggest obstacle to long-term survival. New diagnostic and therapeutic strategies to detect and treat the infectious and immunologically mediated complications of lung transplantation will be needed in the future.
在现代肺移植时代,成功面临的主要挑战是移植物感染和排斥问题。肺是移植后几乎肯定会发生感染的唯一实体器官。肺移植候选者的临床管理包括检测既往和当前感染以及进行适当的免疫接种。针对肺移植后感染的积极预防方案是根据个体患者的基础疾病和感染史量身定制的。高度的怀疑指数和频繁检测,包括快速病毒诊断以及带支气管肺泡灌洗的可弯曲纤维支气管镜检查,已成为移植后医疗管理的标准。与接受其他实体器官移植的患者相比,肺移植受者发生急性和慢性移植物排斥问题似乎更频繁、更严重。对早期急性移植物排斥的预判和积极治疗是移植后最初几个月患者护理的关键方面。由慢性移植物排斥引起的闭塞性细支气管炎是长期生存的最大障碍。未来将需要新的诊断和治疗策略来检测和治疗肺移植的感染性和免疫介导并发症。